[HTML] frontiersin.org

[HTML][HTML] Precision medicine approaches to overcome resistance to therapy in head and neck cancers

S Ortiz-Cuaran, J Bouaoud, A Karabajakian… - Frontiers in …, 2021 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …
被引用次数：43 相关文章
[HTML] nih.gov

[HTML][HTML] Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers

S Ortiz-Cuaran, J Bouaoud, A Karabajakian… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers

S Ortiz-Cuaran, J Bouaoud… - Frontiers in …, 2021 - univ-lyon1.hal.science
Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers

S Ortiz-Cuaran, J Bouaoud… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers.

S Ortiz-Cuaran, J Bouaoud, A Karabajakian… - Frontiers in …, 2021 - europepmc.org
Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers

S Ortiz-Cuaran, J Bouaoud, A Karabajakian… - Frontiers in …, 2021 - hal-ciheam.iamm.fr
Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers

S Ortiz-Cuaran, J Bouaoud, A Karabajakian… - Frontiers in …, 2021 - hal.univ-smb.fr
Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers. Front

S Ortiz-Cuaran, J Bouaoud… - … of Resistance in …, 2022 - books.google.com
Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers

S Ortiz-Cuaran, J Bouaoud, A Karabajakian… - Frontiers in …, 2021 - hal.science
Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers

S Ortiz-Cuaran, J Bouaoud, A Karabajakian… - Frontiers in …, 2021 - cir.nii.ac.jp
抄録< jats: p> Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident
cancer worldwide. More than half of HNSCC patients experience locoregional or distant …